A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Interferon Alpha-2b and 5-FU Alone or in Combination with Either External Radiation Treatment and Cisplatin (CapRI) or Radiation alone regarding Event-Free Survival – CapRI-2

BACKGROUND: The 5-year survival of patients with resected pancreatic adenocarcinoma is still unsatisfying. The ESPAC-1 and the CONKO 001 trial proofed that adjuvant chemotherapy improves 5-year survival significantly from approximately 14% to 21%. In parallel, investigators from the Virginia Mason C...

Descripción completa

Detalles Bibliográficos

Autores principales:	Märten, Angela, Schmidt, Jan, Ose, Jennifer, Harig, Sabine, Abel, Ulrich, Münter, Marc W, Jäger, Dirk, Friess, Helmut, Mayerle, Julia, Adler, Guido, Seufferlein, Thomas, Gress, Thomas, Schmid, Roland, Büchler, Markus W
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696468/ https://www.ncbi.nlm.nih.gov/pubmed/19470159 http://dx.doi.org/10.1186/1471-2407-9-160